MICROED / 3D ED / PHARMACEUTICAL SOLID FORMS

MicroED and 3D Electron Diffraction: Pharmaceutical Literature, 2018–2026

Selected MicroED and 3D electron diffraction publications on pharmaceutical crystal structures, polymorphs, salts, cocrystals, solvates, drug products, and absolute configuration.

Selected for pharmaceutical relevance, methodological contribution, industrial evidence, and review value. This is an editorial collection, not a citation-count ranking or an exhaustive bibliography. Foundational 2018 studies are included.

52 verified publications · bilingual guides · original DOIs and dates

19 publications match these filters

Foundational studies

Structure Revision of the Lomaiviticins

Lee Joon Kim; Mengzhao Xue; Xin Li et al.
Journal of the American Chemical Society · DOI 10.1021/jacs.1c01729

MicroED analysis of lomaiviticin C prompted revision of its molecular connectivity and stereochemical assignments. High-field NMR and computational analysis supported the revised interpretation, with implications for related lomaiviticins. This is a natural-product structure-elucidation landmark rather than a pharmaceutical-polymorph study, demonstrating the value of complementary methods when complex, sparsely protonated molecules resist confident NMR assignment.

Why it is included: Landmark natural-product structure revision supported by MicroED and orthogonal evidence.

Pharmaceutical case studies

Structural analysis of metastable pharmaceutical loratadine form II, by 3D electron diffraction and DFT+D energy minimisation

Grahame R. Woollam; Partha P. Das; Enrico Mugnaioli; Iryna Andrusenko; Athanassios S. Galanis; Jacco van de Streek; Stavros Nicolopoulos; Mauro Gemmi; Trixie Wagner
CrystEngComm · DOI 10.1039/d0ce01216e

Researchers combined room-temperature, limited-resolution three-dimensional electron diffraction with density-functional energy minimization to determine metastable loratadine Form II. Direct methods were insufficient because of resolution, disorder, and possible beam-induced amorphization. Simulated annealing generated candidate models, and computational validation selected the correct structure, illustrating a complementary experimental and computational workflow for challenging pharmaceutical polymorphs.

Why it is included: Direct metastable API polymorph application showing how computation can complement limited-resolution diffraction data.

Pharmaceutical case studies

Indomethacin Polymorph δ Revealed To Be Two Plastically Bendable Crystal Forms by 3D Electron Diffraction: Correcting a 47‐Year‐Old Misunderstanding

Molly Lightowler; Shuting Li; Xiao Ou et al.
Angewandte Chemie International Edition · DOI 10.1002/anie.202114985

Three-dimensional electron diffraction showed that solution-grown and melt-grown materials previously grouped as delta-indomethacin have different crystal structures. The authors retained delta for the solution-grown form and proposed theta for the melt-grown form. Both displayed plastic bending associated with molecular slip. This case demonstrates how structural measurements can resolve longstanding ambiguity in polymorph identity.

Why it is included: Corrects a decades-old ambiguity in an extensively studied pharmaceutical polymorph system.

Pharmaceutical case studies

Direct structure determination of vemurafenib polymorphism from compact spherulites using 3D electron diffraction

Shuting Li; Molly Lightowler; Xiao Ou et al.
Communications Chemistry · DOI 10.1038/s42004-022-00804-2

Researchers determined the structures of five vemurafenib polymorphs directly from compact spherulites using 3D electron diffraction. Three matched known single-crystal X-ray structures, while the method resolved a difficult delta form and a newly observed epsilon form. The work expands access to melt-grown polymorphs whose morphology or instability can frustrate conventional single-crystal analysis.

Why it is included: Multi-polymorph API demonstration including difficult and newly discovered forms.

Pharmaceutical case studies

Distinct Conformations of Mirabegron Determined by MicroED

Jieye Lin; Johan Unge; Tamir Gonen
Advanced Science · DOI 10.1002/advs.202304476

MicroED analysis of mirabegron nanocrystals revealed two molecular conformers within the asymmetric unit and a hydrogen-bonded packing arrangement. The authors compared these solid-state conformations with a previously reported receptor-bound model and discussed differences. The two conformers are not, by themselves, evidence of two separate polymorphs; the study concerns molecular conformation within the observed crystal structure.

Why it is included: Direct powder-derived API structure with explicit conformational interpretation.

Pharmaceutical case studies

Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED

Guanhong Bu; Emma Danelius; Lianne H.E. Wieske; Tamir Gonen
Advanced Biology · DOI 10.1002/adbi.202300570

Researchers determined two polymorphic crystal structures of the oral macrocyclic drug paritaprevir within the same MicroED experiment. The forms differed in macrocycle and substituent conformations. Docking suggested that one conformation could fit the viral protease binding pocket. The structural and computational results inform conformational analysis but do not establish a difference in clinical performance between polymorphs.

Why it is included: A direct macrocyclic-drug example connecting polymorphism with molecular conformation, useful for solid-form selection and interpretation of structural models.

Pharmaceutical case studies

Phase Identification and Discovery of an Elusive Polymorph of Drug‐Polymer Inclusion Complex Using Automated 3D Electron Diffraction

Molly Lightowler; Shuting Li; Xiao Ou; Jungyoun Cho; Binbin Liu; Ao Li; Gerhard Hofer; Jiaoyan Xu; Taimin Yang; Xiaodong Zou; Ming Lu; Hongyi Xu
Angewandte Chemie International Edition · DOI 10.1002/anie.202317695

An automated low-dose 3D electron diffraction workflow identified six phases in a melt-crystallized griseofulvin–polyethylene glycol system. More than 230 datasets were collected and processed in three days. The researchers resolved known drug polymorphs and inclusion complexes alongside an elusive new inclusion-complex phase, then related the two inclusion-complex polymorphs to their structural stability differences.

Why it is included: A strong pharmaceutical screening case showing how automated crystal-by-crystal analysis can uncover minor phases in complex, beam-sensitive crystallization products.

Pharmaceutical case studies

Rapid Structure Determination of Ranitidine Hydrochloride API in Two Crystal Forms Using Microcrystal Electron Diffraction

Hidetomo Yokoo; Yoshitaka Aoyama; Takashi Matsumoto; Eiichi Yamamoto; Nahoko Uchiyama; Yosuke Demizu
Chemical and Pharmaceutical Bulletin · DOI 10.1248/cpb.c23-00745

Researchers used MicroED to determine the crystal structures of ranitidine hydrochloride Forms 1 and 2. The resulting structures agreed with previously reported X-ray diffraction structures. The work presents a focused pharmaceutical proof of applicability for small-quantity or microcrystalline API samples, while retaining the need to control crystal form, hydration, and residual solvents through complementary quality assessments.

Why it is included: A straightforward API polymorph comparison that helps readers evaluate MicroED against established X-ray structures rather than relying solely on novel discoveries.

Pharmaceutical case studies

Polyethylene Glycol-Assisted Melt Crystallization of Two New Piroxicam Polymorphs Revealed by 3D Electron Diffraction

Jiaoyan Xu; Changlin Yao; Shufang Zhang; Xiaodong Zou; Yue Gui; Lei Wang; Hongyi Xu
Crystal Growth & Design · DOI 10.1021/acs.cgd.4c00951

Two previously unreported piroxicam polymorphs, Forms VIII and IX, emerged through polyethylene glycol-assisted melt crystallization. Their crystal structures were determined by 3D electron diffraction. Comparing the newly solved Form VIII with known Form IV allowed discussion of how differences in intermolecular hydrogen bonding contribute to melting behavior. The study concerns laboratory solid forms rather than validated drug-product performance.

Why it is included: Illustrates how polymer-assisted screening and 3D ED can jointly expand a well-studied API’s polymorph landscape and explain thermal-property differences.

Pharmaceutical case studies

From formulation to structure: 3D electron diffraction for the structure solution of a new indomethacin polymorph from an amorphous solid dispersion

Helen W. Leung; Royston C. B. Copley; Giulio I. Lampronti; Sarah J. Day; Lucy K. Saunders; Duncan N. Johnstone; Paul A. Midgley
IUCrJ · DOI 10.1107/s2052252524008121

3D electron diffraction resolved the structure of the ninth reported indomethacin polymorph, designated sigma, from crystals found within an amorphous solid dispersion. Subsequent experiments produced the same form by solvent evaporation. The work demonstrates structure determination directly from a formulation-related sample containing an excipient; it does not establish improved dissolution or clinical performance for the new form.

Why it is included: A highly relevant formulation case linking unexpected crystallinity in an ASD with definitive structure determination and a follow-up crystallization route.

Pharmaceutical case studies

SCXRD, CSP-NMRX and microED in the quest for three elusive polymorphs of meloxicam

Agata Jeziorna; Maura Malinska; Isaac Sugden; Piotr Paluch; Rafał Dolot; Marta K. Dudek
IUCrJ · DOI 10.1107/s2052252524011898

Three elusive meloxicam polymorphs required different structure-determination approaches. Single-crystal X-ray diffraction solved Form III, combined crystal structure prediction and NMR crystallography solved Form II, and electron diffraction resolved Form V, which contains four independent molecules in the asymmetric unit. The comparison highlights complementary strengths and limitations rather than establishing one universally superior crystallographic method.

Why it is included: A useful method-selection study for challenging drug polymorphs, illustrating why MicroED, CSP, solid-state NMR, and X-ray diffraction belong in one toolkit.

Pharmaceutical case studies

Structural Analysis of Active Pharmaceutical Ingredients in Tablets Using 3D ED/MicroED

Keiyo Nakai; Takashi Kikuchi; Kuniyoshi Miki; Akito Sasaki; Mitsuhisa Yamano
Molecular Pharmaceutics · DOI 10.1021/acs.molpharmaceut.5c00028

The study examined API crystals directly in Allegra, Clarith, and Ibrance tablets using selected-area 3D ED/MicroED. Fexofenadine hydrochloride Form I and clarithromycin Form II retained their polymorphs, while palbociclib Form A showed slight lattice shrinkage. The results demonstrate formulation-level structural analysis and emphasize that a lattice change and a new polymorph are different findings.

Why it is included: Direct tablet measurements make this a particularly useful reference for formulation development, manufacturing comparisons, and investigating API form changes in finished products.

Continue your research

Explore company filters, side-by-side comparisons, private bookmarks, and member discussions.

Open free member tools ↗
AI assistant ↗